Results 101 to 110 of about 5,794 (166)

Homozygous Familial Hypercholesterolemia in a Seven-Year-Old: A Case Study Highlighting the Importance of Early Diagnosis. [PDF]

Cureus
Bensabbahia D, El Achiwi M, Atrassi M, Abkari A, Widad G.   +4 more
europepmc   +1 more source

Lomitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, in Homozygous Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Efficacy and Safety. [PDF]

Cardiovasc Drugs Ther
Nasser M, Mohammed HE, Haseeb ME, Darwish MK, Hanen G, Abdelaziz NA, Heiba AH, Shata A, Abdelkader MS.   +8 more
europepmc   +1 more source

Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia. [PDF]

JACC Case Rep
Alkhairy A, Xiang P, Khoo JK, Taylor CM, Francis GA.   +4 more
europepmc   +1 more source

Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era. [PDF]

J Am Coll Cardiol
Mulder JWCM, Reijman MD, Kusters DM, Boersma E, Alnouri F, Blom DJ, Catapano AL, Cuchel M, Dann EJ, Freiberger T, Groselj U, Harada-Shiba M, Hovingh GK, Iatan I, Ibarretxe D, Kayikcioglu M, Kim NT, Klingel R, Raal FJ, Reeskamp LF, Sadiq F, Schonck WAM, Tromp TR, Truong TH, Wiegman A, Roeters van Lennep JE, Homozygous Familial Hypercholesterolemia International Clinical Collaborators.   +26 more
europepmc   +1 more source

Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary. [PDF]

Future Cardiol
Gaudet D, Greber-Platzer S, Reeskamp LF, Iannuzzo G, Rosenson RS, Saheb S, Stefanutti C, Stroes E, Wiegman A, Turner T, Ali S, Banerjee P, McGinniss J, Waldron A, George RT, Zhao XQ, Pordy R, Bruckert E, Raal FJ.   +18 more
europepmc   +1 more source

Population Pharmacokinetics and Exposure-Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial Hypercholesterolemia. [PDF]

CPT Pharmacometrics Syst Pharmacol
Bihorel S, Dingman R, Mendell J, Wang Y, Banerjee P, Pordy R, Davis JD, DiCioccio AT, Harnisch L.   +8 more
europepmc   +1 more source

A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia. [PDF]

Med Res Arch
Morales A, Jamison A, Hegele RA, Hemphill L, Gidding SS.   +4 more
europepmc   +1 more source

Liver transplantation for homozygous familial hypercholesterolemia: a retrospective analysis from Chinese experience. [PDF]

Orphanet J Rare Dis
Zhan HS, Wei L, Qu W, Zeng ZG, Liu Y, Tan YL, Wang J, Zhang L, He EH, Zhou GP, Zhang HM, Zhu ZJ, Sun LY.   +12 more
europepmc   +1 more source

Outpatient monthly plasmapheresis with post-PLEX evinacumab in pediatric homozygous familial hypercholesterolemia: a case report on port access and immunoglobulin preservation. [PDF]

Front Pediatr
Filler G, Norozi K.
europepmc   +1 more source

Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia. [PDF]

CPT Pharmacometrics Syst Pharmacol
Bihorel S, Dingman R, Mendell J, Norman KC, George RT, Zhao XQ, Pordy R, Garcia D, Putnam WS, Raghuveer G, McCrindle BW, Fornari E, Baric I, Srinivasan S, Diamond M, Brinton EA, Davis JD, DiCioccio AT, Harnisch L.   +18 more
europepmc   +1 more source